WilliamHShermanMD

PubMed

• 11 citations
  Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy
  William H. Sherman, Elizabeth M. Hecht, David Leung, Kyung Chu> ;The Oncologist. 2018 Jan 1
• 6 citations
  Fludarabine in the Treatment of Refractory Chronic Inflammatory Demyelinating Neuropathies.
  Megan Leitch, William H. Sherman, Thomas H. Brannagan> ;Journal of Clinical Neuromuscular Disease. 2015 Sep 1
• 38 citations
  Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreati...
  William H. Sherman, Kyung Chu, John A. Chabot, John D. Allendorf, Beth Schrope, Elizabeth M. Hecht, Brian Jin, David Leung, Helen Remotti, Gisella Addeo, Inna Postolov...> ;Cancer. 2015 Mar 1
• 15 citations
  Acquired Cutis Laxa Associated With Heavy Chain Deposition Disease Involving Dermal Elastic Fibers
  John T. O'Malley, Vivette D. D'Agati, William H. Sherman, Marc E. Grossman> ;JAMA Dermatology. 2014 Nov 1
• 41 citations
  An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma
  Kevin O’Bryan, William H. Sherman, George W. Niedt, Bret Taback, Spiros Manolidis, Antai Wang, Désirée Ratner> ;Journal of the American Academy of Dermatology. 2013 Oct 1
• 180 citations
  Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
  Robert L. Fine, Anthony Paul Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen M. Schreibman, Dawn Tsushima, Kelley B. Mowatt, Richard D. Dinnen, Yuehua Mao, Peter ...> ;Cancer Chemotherapy and Pharmacology. 2013 Jan 31
• 14 citations
  Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cycloph...
  Megan M. Leitch, William H. Sherman, Thomas H. Brannagan> ;Muscle & Nerve. 2013 Feb 1
• 21 citations
  Complete Clinical Response to Cetuximab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma
  Kristen Miller, William Sherman, Désirée Ratner> ;Dermatologic Surgery. 2010 Dec 1
• 12 citations
  Using imatinib as neoadjuvant therapy in dermatofibrosarcoma protuberans: potential pluses and minuses.
  Hillary Johnson-Jahangir, William H. Sherman, Désirée Ratner> ;Journal of the National Comprehensive Cancer Network. 2010 Aug 1
• 2 citations
  Sirolimus can reverse resistance to gemcitabine, capecitabine and docetaxel combination therapy in pancreatic cancer.
  William H. Sherman> ;JOP. 2009 Jul 6
• 39 citations
  Neoadjuvant Imatinib Therapy for Dermatofibrosarcoma Protuberans
  Anne Han, Elbert H. Chen, George W. Niedt, William H. Sherman, Désirée Ratner> ;Archives of Dermatology. 2009 Jul 1
• 58 citations
  Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma.
  Howard L. Kaufman, Bret Taback, William H. Sherman, Dae Won Kim, William Shingler, Dorota Moroziewicz, Gail DeRaffele, Josephine Mitcham, Miles W. Carroll, Richard Har...> ;Journal of Translational Medicine. 2009 Jan 7
• 68 citations
  Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival
  John D. Allendorf, Margaret H. Lauerman, Aliye Z. Bill, Mary DiGiorgi, Nicole Goetz, Efsevia Vakiani, Helen Remotti, Beth Schrope, William H. Sherman, Michael J. Hall,...> ;Journal of Gastrointestinal Surgery. 2008 Jan 1
• 73 citations
  The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
  Robert L. Fine, David R. Fogelman, Stephen M. Schreibman, Manisha Desai, William H. Sherman, James Strauss, Susan Guba, Riolan Andrade, John A. Chabot> ;Cancer Chemotherapy and Pharmacology. 2007 Apr 18
• 35 citations
  Sorafenib-induced erythema multiforme
  Jennifer L. MacGregor, David N. Silvers, Marc E. Grossman, William H. Sherman> ;Journal of the American Academy of Dermatology. 2007 Mar 1
• 27 citations
  Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers
  Jeffrey N. Weitzel, Saundra S. Buys, William H. Sherman, Anna Marie Daniels, Giske Ursin, Deborah J. MacDonald, Kathleen R. Blazer, Malcolm C. Pike, Darcy V. Spicer> ;Clinical Cancer Research. 2007 Jan 15
• 66 citations
  Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy.
  Russell L. Chin, William H. Sherman, Howard W. Sander, Arthur P. Hays, Norman Latov> ;Journal of the Neurological Sciences. 2003 Jun 15
• 7 citations
  Fludarabine treatment of cryoglobulinemic glomerulonephritis.
  Jordan L. Rosenstock, Leonard Stern, William H. Sherman, Gerald B. Appel, Jai Radhakrishnan> ;American Journal of Kidney Diseases. 2002 Sep 1
• 265 citations
  Renal monoclonal immunoglobulin deposition disease : The disease spectrum
  Julie Lin, Glen S. Markowitz, Anthony M. Valeri, Neeraja Kambham, William H. Sherman, G B Appel, Vivette D. D'Agati> ;Journal of the American Society of Nephrology. 2001 Jul 1
• 46 citations
  Combination Gemcitabine and Docetaxel Therapy in Advanced Adenocarcinoma of the Pancreas
  William H. Sherman, Robert L. Fine> ;Oncology. 2001 Jan 1
• 31 citations
  Evidence against KSHV infection in the pathogenesis of multiple myeloma.
  Sonja J. Olsen, Karin Tarte, William H. Sherman, Evelyn E. Hale, Marie T. Weisse, Attilio Orazi, Bernard Klein, Yuan Chang> ;Virus Research. 1998 Oct 1
• 90 citations
  Lymphoproliferative disorders and motor neuron disease An update
  Paul H. Gordon, Lewis P. Rowland, David S. Younger, William H. Sherman, A. P. Hays, Elan D. Louis, Dale J. Lange, Werner Trojaborg, Robert E. Lovelace, P. L. Murphy, N...> ;Neurology. 1997 Jun 1
• 14 citations
  Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy
  Elan D. Louis, Ann E. Hanley, Thomas H. Brannagan, William H. Sherman, P. L. Murphy, Dale J. Lange, Werner Trojaborg, David S. Younger, Robert E. Lovelace, Norman Lato...> ;Muscle & Nerve. 1996 Oct 1
• 86 citations
  Anti‐MAG and anti‐SGPG antibodies in neuropathy
  Leonard H. van den Berg, Arthur P. Hays, Eduardo Nobile-Orazio, Lawrence J. Kinsella, E. Manfredini, Massimo Corbo, Gorazd Rosoklija, David S. Younger, Robert E. Lovel...> ;Muscle & Nerve. 1996 May 1
• 55 citations
  Anti-Hu-associated peripheral nerve and muscle microvasculitis.
  David S. Younger, Josep Dalmau, Giorgio Inghirami, William H. Sherman, Arthur P. Hays> ;Neurology. 1994 Jan 1
• Join now to see all